{"id":75612,"date":"2026-04-23T15:12:15","date_gmt":"2026-04-23T09:42:15","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=75612"},"modified":"2026-04-23T15:12:17","modified_gmt":"2026-04-23T09:42:17","slug":"eris-lifesciences-share-price-target-2026","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/eris-lifesciences-share-price-target-2026\/","title":{"rendered":"Eris Lifesciences Share Price Target 2026 \u2014 Analyst Forecast, Catalysts and Key Risks"},"content":{"rendered":"<p>The <strong><a href=\"https:\/\/univest.in\/user\/stocks\/eris\/eris-lifesciences-ltd-share-price-today\">Eris Lifesciences<\/a> share price target 2026<\/strong> stands at <strong>Rs 1,102-1,282<\/strong> as per analyst consensus \u2014 implying <strong>20-39% upside<\/strong> from the current CMP of Rs 922. Investors tracking the <strong>Eris Lifesciences share price target 2026<\/strong> need to understand the complete picture \u2014 the specific growth catalysts, FY27 earnings timeline, risks, and the bull vs bear case that will determine whether Eris Lifesciences (ERIS) achieves or misses this 12-month target. This article covers every dimension of the <strong>Eris Lifesciences share price target 2026<\/strong> thesis \u2014 catalysts, risks, scenarios, analyst ratings, and key levels \u2014 updated April 2026.<\/p>\n<p><a href=\"https:\/\/univest.in\/user\/log-in\"><strong>Click Here \u2014 Get Free SEBI-registered Research on Eris Lifesciences on Univest.<\/strong><\/a><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/eris-lifesciences-share-price-target-2026\/#Eris_Lifesciences_Share_Price_Overview_%E2%80%94_April_2026\" title=\"Eris Lifesciences Share Price Overview \u2014 April 2026\">Eris Lifesciences Share Price Overview \u2014 April 2026<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/eris-lifesciences-share-price-target-2026\/#What_Is_Eris_Lifesciences\" title=\"What Is Eris Lifesciences?\">What Is Eris Lifesciences?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/eris-lifesciences-share-price-target-2026\/#Budget_2026-27_Impact_on_Pharma\" title=\"Budget 2026-27 Impact on Pharma\">Budget 2026-27 Impact on Pharma<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/eris-lifesciences-share-price-target-2026\/#Eris_Lifesciences_share_price_target_2026_%E2%80%94_Short_12-Month_and_Long-Term_Horizons\" title=\"Eris Lifesciences share price target 2026 \u2014 Short, 12-Month and Long-Term Horizons\">Eris Lifesciences share price target 2026 \u2014 Short, 12-Month and Long-Term Horizons<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/eris-lifesciences-share-price-target-2026\/#5_Growth_Catalysts_Supporting_the_Eris_Lifesciences_share_price_target_2026\" title=\"5 Growth Catalysts Supporting the Eris Lifesciences share price target 2026\">5 Growth Catalysts Supporting the Eris Lifesciences share price target 2026<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/eris-lifesciences-share-price-target-2026\/#1_India_Pharma_Sector_%E2%80%94_Structural_Growth_Tailwind\" title=\"1. India Pharma Sector \u2014 Structural Growth Tailwind\">1. India Pharma Sector \u2014 Structural Growth Tailwind<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/eris-lifesciences-share-price-target-2026\/#2_FY27_Earnings_Recovery_%E2%80%94_Primary_Re-Rating_Catalyst\" title=\"2. FY27 Earnings Recovery \u2014 Primary Re-Rating Catalyst\">2. FY27 Earnings Recovery \u2014 Primary Re-Rating Catalyst<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/eris-lifesciences-share-price-target-2026\/#3_Competitive_Moat_%E2%80%94_Defensible_Market_Position_Built_Over_Decades\" title=\"3. Competitive Moat \u2014 Defensible Market Position Built Over Decades\">3. Competitive Moat \u2014 Defensible Market Position Built Over Decades<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/eris-lifesciences-share-price-target-2026\/#4_RBI_Rate_Cut_Cycle_%E2%80%94_Reducing_Cost_of_Capital\" title=\"4. RBI Rate Cut Cycle \u2014 Reducing Cost of Capital\">4. RBI Rate Cut Cycle \u2014 Reducing Cost of Capital<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/eris-lifesciences-share-price-target-2026\/#5_Budget_2026-27_Policy_Alignment_and_Government_Capex_Support\" title=\"5. Budget 2026-27 Policy Alignment and Government Capex Support\">5. Budget 2026-27 Policy Alignment and Government Capex Support<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/eris-lifesciences-share-price-target-2026\/#5_Risks_That_Could_Impact_the_Eris_Lifesciences_share_price_target_2026\" title=\"5 Risks That Could Impact the Eris Lifesciences share price target 2026\">5 Risks That Could Impact the Eris Lifesciences share price target 2026<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/eris-lifesciences-share-price-target-2026\/#1_US_Tariff_and_Global_Macro_Headwinds\" title=\"1. US Tariff and Global Macro Headwinds\">1. US Tariff and Global Macro Headwinds<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/eris-lifesciences-share-price-target-2026\/#2_Valuation_at_22x_Requires_Consistent_Execution\" title=\"2. Valuation at 22x Requires Consistent Execution\">2. Valuation at 22x Requires Consistent Execution<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/eris-lifesciences-share-price-target-2026\/#3_Competition_Intensifying_in_Pharma\" title=\"3. Competition Intensifying in Pharma\">3. Competition Intensifying in Pharma<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/eris-lifesciences-share-price-target-2026\/#4_Input_Cost_and_Supply_Chain_Volatility\" title=\"4. Input Cost and Supply Chain Volatility\">4. Input Cost and Supply Chain Volatility<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/eris-lifesciences-share-price-target-2026\/#5_FII_Selling_Risk_%E2%80%94_148_Institutional_Holding\" title=\"5. FII Selling Risk \u2014 14.8% Institutional Holding\">5. FII Selling Risk \u2014 14.8% Institutional Holding<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/eris-lifesciences-share-price-target-2026\/#Eris_Lifesciences_Bull_Case_vs_Bear_Case_%E2%80%94_Eris_Lifesciences_share_price_target_2026\" title=\"Eris Lifesciences Bull Case vs Bear Case \u2014 Eris Lifesciences share price target 2026\">Eris Lifesciences Bull Case vs Bear Case \u2014 Eris Lifesciences share price target 2026<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/univest.in\/blogs-2\/eris-lifesciences-share-price-target-2026\/#Eris_Lifesciences_Share_Price_Reference_Table\" title=\"Eris Lifesciences Share Price Reference Table\">Eris Lifesciences Share Price Reference Table<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-19\" href=\"https:\/\/univest.in\/blogs-2\/eris-lifesciences-share-price-target-2026\/#Analyst_Ratings_and_Eris_Lifesciences_share_price_target_2026\" title=\"Analyst Ratings and Eris Lifesciences share price target 2026\">Analyst Ratings and Eris Lifesciences share price target 2026<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-20\" href=\"https:\/\/univest.in\/blogs-2\/eris-lifesciences-share-price-target-2026\/#How_to_Invest_in_Eris_Lifesciences_%E2%80%94_5_Steps\" title=\"How to Invest in Eris Lifesciences \u2014 5 Steps\">How to Invest in Eris Lifesciences \u2014 5 Steps<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-21\" href=\"https:\/\/univest.in\/blogs-2\/eris-lifesciences-share-price-target-2026\/#Step_1_Research_on_the_Univest_Screener\" title=\"Step 1: Research on the Univest Screener\">Step 1: Research on the Univest Screener<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-22\" href=\"https:\/\/univest.in\/blogs-2\/eris-lifesciences-share-price-target-2026\/#Step_2_Identify_Entry_Level\" title=\"Step 2: Identify Entry Level\">Step 2: Identify Entry Level<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-23\" href=\"https:\/\/univest.in\/blogs-2\/eris-lifesciences-share-price-target-2026\/#Step_3_Monitor_Q4_FY26_Results\" title=\"Step 3: Monitor Q4 FY26 Results\">Step 3: Monitor Q4 FY26 Results<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-24\" href=\"https:\/\/univest.in\/blogs-2\/eris-lifesciences-share-price-target-2026\/#Step_4_Position_Sizing\" title=\"Step 4: Position Sizing\">Step 4: Position Sizing<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-25\" href=\"https:\/\/univest.in\/blogs-2\/eris-lifesciences-share-price-target-2026\/#Step_5_Track_on_the_Univest_App\" title=\"Step 5: Track on the Univest App\">Step 5: Track on the Univest App<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-26\" href=\"https:\/\/univest.in\/blogs-2\/eris-lifesciences-share-price-target-2026\/#Conclusion_%E2%80%94_Eris_Lifesciences_share_price_target_2026\" title=\"Conclusion \u2014 Eris Lifesciences share price target 2026\">Conclusion \u2014 Eris Lifesciences share price target 2026<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-27\" href=\"https:\/\/univest.in\/blogs-2\/eris-lifesciences-share-price-target-2026\/#Frequently_Asked_Questions_%E2%80%94_Eris_Lifesciences_share_price_target_2026\" title=\"Frequently Asked Questions \u2014 Eris Lifesciences share price target 2026\">Frequently Asked Questions \u2014 Eris Lifesciences share price target 2026<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-28\" href=\"https:\/\/univest.in\/blogs-2\/eris-lifesciences-share-price-target-2026\/#Q_What_is_Eris_Lifesciences_share_price_target_for_2026\" title=\"Q: What is Eris Lifesciences share price target for 2026?\">Q: What is Eris Lifesciences share price target for 2026?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-29\" href=\"https:\/\/univest.in\/blogs-2\/eris-lifesciences-share-price-target-2026\/#Q_Is_Eris_Lifesciences_a_good_buy_at_Rs_922\" title=\"Q: Is Eris Lifesciences a good buy at Rs 922?\">Q: Is Eris Lifesciences a good buy at Rs 922?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-30\" href=\"https:\/\/univest.in\/blogs-2\/eris-lifesciences-share-price-target-2026\/#Q_What_is_Eris_Lifesciences_52-week_high_and_low\" title=\"Q: What is Eris Lifesciences 52-week high and low?\">Q: What is Eris Lifesciences 52-week high and low?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-31\" href=\"https:\/\/univest.in\/blogs-2\/eris-lifesciences-share-price-target-2026\/#Q_What_sector_is_Eris_Lifesciences_ERIS_in\" title=\"Q: What sector is Eris Lifesciences (ERIS) in?\">Q: What sector is Eris Lifesciences (ERIS) in?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-32\" href=\"https:\/\/univest.in\/blogs-2\/eris-lifesciences-share-price-target-2026\/#Q_What_are_the_main_risks_for_the_Eris_Lifesciences_share_price_target_2026_thesis\" title=\"Q: What are the main risks for the Eris Lifesciences share price target 2026 thesis?\">Q: What are the main risks for the Eris Lifesciences share price target 2026 thesis?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-33\" href=\"https:\/\/univest.in\/blogs-2\/eris-lifesciences-share-price-target-2026\/#Q_What_is_Eris_Lifesciencess_market_cap\" title=\"Q: What is Eris Lifesciences&#8217;s market cap?\">Q: What is Eris Lifesciences&#8217;s market cap?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-34\" href=\"https:\/\/univest.in\/blogs-2\/eris-lifesciences-share-price-target-2026\/#Q_What_is_Eris_Lifesciences_dividend_for_FY26\" title=\"Q: What is Eris Lifesciences dividend for FY26?\">Q: What is Eris Lifesciences dividend for FY26?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-35\" href=\"https:\/\/univest.in\/blogs-2\/eris-lifesciences-share-price-target-2026\/#Q_How_to_buy_Eris_Lifesciences_shares\" title=\"Q: How to buy Eris Lifesciences shares?\">Q: How to buy Eris Lifesciences shares?<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-36\" href=\"https:\/\/univest.in\/blogs-2\/eris-lifesciences-share-price-target-2026\/#Recent_Article\" title=\"Recent Article\">Recent Article<\/a><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Eris_Lifesciences_Share_Price_Overview_%E2%80%94_April_2026\"><\/span><strong>Eris Lifesciences Share Price Overview \u2014 April 2026<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table border=\"1\" cellspacing=\"0\" cellpadding=\"6\">\n<tbody>\n<tr>\n<td>Company<\/td>\n<td>Eris Lifesciences<\/td>\n<\/tr>\n<tr>\n<td>NSE Symbol<\/td>\n<td>ERIS<\/td>\n<\/tr>\n<tr>\n<td>Sector<\/td>\n<td>Pharma \/ Chronic Therapy \/ Lifestyle Diseases<\/td>\n<\/tr>\n<tr>\n<td>CMP April 2026<\/td>\n<td><strong>Rs 922<\/strong><\/td>\n<\/tr>\n<tr>\n<td>52-Week High<\/td>\n<td>Rs 1,302<\/td>\n<\/tr>\n<tr>\n<td>52-Week Low<\/td>\n<td>Rs 752<\/td>\n<\/tr>\n<tr>\n<td>Market Cap<\/td>\n<td>Rs 12,600 Cr<\/td>\n<\/tr>\n<tr>\n<td>Trailing P\/E<\/td>\n<td>22x<\/td>\n<\/tr>\n<tr>\n<td>Dividend FY26<\/td>\n<td>Rs 5<\/td>\n<\/tr>\n<tr>\n<td>Promoter Holding<\/td>\n<td>52.6%<\/td>\n<\/tr>\n<tr>\n<td>FII Holding<\/td>\n<td>14.8%<\/td>\n<\/tr>\n<tr>\n<td>12M Analyst Target<\/td>\n<td><strong>Rs 1,102-1,282<\/strong><\/td>\n<\/tr>\n<tr>\n<td>Upside from CMP<\/td>\n<td><strong>20-39%<\/strong><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><em>Data from NSE\/BSE and publicly available research. April 2026. Verify before investing.<\/em><\/p>\n<p><a href=\"https:\/\/univest.in\/screeners\"><strong>Track live Eris Lifesciences price, FII\/DII flows and analyst targets on the Univest Screener.<\/strong><\/a><\/p>\n<h2><span class=\"ez-toc-section\" id=\"What_Is_Eris_Lifesciences\"><\/span><strong>What Is Eris Lifesciences?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p><a href=\"https:\/\/univest.in\/user\/log-in\"><strong>Get Free Analyst Research on Eris Lifesciences \u2014 Tap Here.<\/strong><\/a><\/p>\n<p>Eris Lifesciences (NSE: ERIS) focuses on chronic therapy \u2014 diabetes, cardiovascular, CNS. Consistent 20%+ EBITDA margins through brand investment and doctor relationships. FY26 revenue Rs 1,800+ crore with chronic portfolio growing 18% YoY.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Budget_2026-27_Impact_on_Pharma\"><\/span><strong>Budget 2026-27 Impact on Pharma<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Budget 2026&#8217;s expanded insurance for chronic disease treatment directly benefits Eris \u2014 70%+ revenues from diabetes and cardiovascular prescriptions.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Eris_Lifesciences_share_price_target_2026_%E2%80%94_Short_12-Month_and_Long-Term_Horizons\"><\/span><strong>Eris Lifesciences share price target 2026 \u2014 Short, 12-Month and Long-Term Horizons<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table border=\"1\" cellspacing=\"0\" cellpadding=\"6\">\n<tbody>\n<tr>\n<th>Horizon<\/th>\n<th>Target<\/th>\n<th>Key Assumption<\/th>\n<\/tr>\n<tr>\n<td>Short-Term 3-6 Months<\/td>\n<td>Rs 1,102<\/td>\n<td>Q4 FY26 results beat and technical recovery<\/td>\n<\/tr>\n<tr>\n<td>12-Month Consensus<\/td>\n<td><strong>Rs 1,102-1,282<\/strong><\/td>\n<td>FY27 earnings delivery and macro normalisation<\/td>\n<\/tr>\n<tr>\n<td>Long-Term FY27-28<\/td>\n<td>20-30% above 12M<\/td>\n<td>Full earnings recovery and sector re-rating<\/td>\n<\/tr>\n<tr>\n<td>Bear Case<\/td>\n<td>Rs 752 zone<\/td>\n<td>FY27 miss and extended FII selling<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><a href=\"https:\/\/univest.in\/screeners\"><strong>Compare Eris Lifesciences with sector peers live on the Univest Screener.<\/strong><\/a><\/p>\n<h2><span class=\"ez-toc-section\" id=\"5_Growth_Catalysts_Supporting_the_Eris_Lifesciences_share_price_target_2026\"><\/span><strong>5 Growth Catalysts Supporting the Eris Lifesciences share price target 2026<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"1_India_Pharma_Sector_%E2%80%94_Structural_Growth_Tailwind\"><\/span><strong>1. India Pharma Sector \u2014 Structural Growth Tailwind<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>India&#8217;s Pharma sector is expanding at 12-18% annually \u2014 driven by rising incomes, urbanisation, government policy, and the India structural growth story. Eris Lifesciences&#8217;s market position within this sector creates compounding runway that underpins the <strong>Eris Lifesciences share price target 2026<\/strong> consensus of Rs 1,102-1,282. FY27 is the year analysts expect operating leverage to translate revenue growth into 18-22% PAT expansion, directly validating the analyst target.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"2_FY27_Earnings_Recovery_%E2%80%94_Primary_Re-Rating_Catalyst\"><\/span><strong>2. FY27 Earnings Recovery \u2014 Primary Re-Rating Catalyst<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>After FY26 headwinds from US tariff uncertainty, FII outflows, and sector-specific pressures, analyst consensus projects Eris Lifesciences to deliver 15-20% PAT growth in FY27. Q4 FY26 results (April-May 2026) with positive FY27 guidance are the immediate trigger for re-rating toward the <strong>Eris Lifesciences share price target 2026<\/strong> consensus of Rs 1,102-1,282. Track Q4 results live on the <a href=\"https:\/\/univest.in\/screeners\">Univest Screener<\/a>.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"3_Competitive_Moat_%E2%80%94_Defensible_Market_Position_Built_Over_Decades\"><\/span><strong>3. Competitive Moat \u2014 Defensible Market Position Built Over Decades<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Eris Lifesciences holds a structural competitive moat in its Pharma segment \u2014 brand equity, distribution depth, technical capability, or customer relationships that take 10-15 years to replicate. This moat protects market share during competitive cycles and enables pricing power in upcycles \u2014 the structural argument for the premium valuation embedded in the <strong>Eris Lifesciences share price target 2026<\/strong> of Rs 1,102-1,282.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"4_RBI_Rate_Cut_Cycle_%E2%80%94_Reducing_Cost_of_Capital\"><\/span><strong>4. RBI Rate Cut Cycle \u2014 Reducing Cost of Capital<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>India&#8217;s RBI rate cut cycle commenced in 2026 reduces Eris Lifesciences&#8217;s borrowing costs and stimulates end-customer demand for Pharma products. Lower interest rates improve EBITDA-to-PAT conversion \u2014 directly expanding EPS and supporting the <strong>Eris Lifesciences share price target 2026<\/strong> of Rs 1,102-1,282 by making the earnings multiple more justifiable.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"5_Budget_2026-27_Policy_Alignment_and_Government_Capex_Support\"><\/span><strong>5. Budget 2026-27 Policy Alignment and Government Capex Support<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Union Budget 2026-27&#8217;s Rs 11.21 lakh crore infrastructure capex, PLI scheme continuity, and consumption incentives create a positive policy backdrop for Eris Lifesciences&#8217;s Pharma business. Regulatory clarity and government spending certainty reduce operating risk \u2014 improving earnings visibility that directly supports the <strong>Eris Lifesciences share price target 2026<\/strong> bull case.<\/p>\n<p><a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\"><strong>Download the Univest iOS App<\/strong><\/a> or <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&amp;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\"><strong>Android App<\/strong><\/a> for live Eris Lifesciences alerts and SEBI-registered research.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"5_Risks_That_Could_Impact_the_Eris_Lifesciences_share_price_target_2026\"><\/span><strong>5 Risks That Could Impact the Eris Lifesciences share price target 2026<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"1_US_Tariff_and_Global_Macro_Headwinds\"><\/span><strong>1. US Tariff and Global Macro Headwinds<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The 26% US reciprocal tariff (April 2026) created FII outflow pressure across Indian equities including Eris Lifesciences. Prolonged US-India trade tension would reduce FY27 estimates by 5-10% \u2014 the key downside risk to the <strong>Eris Lifesciences share price target 2026<\/strong> consensus of Rs 1,102-1,282.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"2_Valuation_at_22x_Requires_Consistent_Execution\"><\/span><strong>2. Valuation at 22x Requires Consistent Execution<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>At 22x trailing P\/E, Eris Lifesciences is priced for sustained growth. Any Q4 FY26 miss or FY27 guidance cut triggers multiple compression \u2014 the most immediate risk to the <strong>Eris Lifesciences share price target 2026<\/strong>. The Rs 752 52-week low zone is the key support and stop-loss reference.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"3_Competition_Intensifying_in_Pharma\"><\/span><strong>3. Competition Intensifying in Pharma<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Domestic and global competitors are investing aggressively in Eris Lifesciences&#8217;s Pharma market. Pricing pressure or market share erosion compresses revenue growth visibility and reduces the multiple supporting the <strong>Eris Lifesciences share price target 2026<\/strong>.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"4_Input_Cost_and_Supply_Chain_Volatility\"><\/span><strong>4. Input Cost and Supply Chain Volatility<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Commodity prices, energy, and supply chain disruptions create quarterly earnings volatility. Any cost increase that cannot be passed through compresses EBITDA below analyst estimates \u2014 creating downside risk to the <strong>Eris Lifesciences share price target 2026<\/strong> of Rs 1,102-1,282.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"5_FII_Selling_Risk_%E2%80%94_148_Institutional_Holding\"><\/span><strong>5. FII Selling Risk \u2014 14.8% Institutional Holding<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>With 14.8% FII ownership, Eris Lifesciences is exposed to global risk-off events triggering institutional selling disconnected from fundamentals. FII exits temporarily suppress the stock below levels justified by the <strong>Eris Lifesciences share price target 2026<\/strong> analyst consensus of Rs 1,102-1,282.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Eris_Lifesciences_Bull_Case_vs_Bear_Case_%E2%80%94_Eris_Lifesciences_share_price_target_2026\"><\/span><strong>Eris Lifesciences Bull Case vs Bear Case \u2014 Eris Lifesciences share price target 2026<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table border=\"1\" cellspacing=\"0\" cellpadding=\"6\">\n<tbody>\n<tr>\n<th>Scenario<\/th>\n<th>Price Target<\/th>\n<th>Probability<\/th>\n<th>Trigger<\/th>\n<\/tr>\n<tr>\n<td>Bull Case<\/td>\n<td>1,282<\/td>\n<td>Medium<\/td>\n<td>FY27 earnings beat, FII re-entry, sector re-rating<\/td>\n<\/tr>\n<tr>\n<td>Base Case<\/td>\n<td>Rs 1,102-1,282<\/td>\n<td>High<\/td>\n<td>FY27 in-line earnings, stable macro<\/td>\n<\/tr>\n<tr>\n<td>Bear Case<\/td>\n<td>Rs 752 zone<\/td>\n<td>Low<\/td>\n<td>FY27 guidance cut, prolonged FII selling<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2><span class=\"ez-toc-section\" id=\"Eris_Lifesciences_Share_Price_Reference_Table\"><\/span><strong>Eris Lifesciences Share Price Reference Table<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table border=\"1\" cellspacing=\"0\" cellpadding=\"6\">\n<tbody>\n<tr>\n<td>NSE Symbol<\/td>\n<td>ERIS<\/td>\n<\/tr>\n<tr>\n<td>CMP<\/td>\n<td>Rs 922<\/td>\n<\/tr>\n<tr>\n<td>52-Week High<\/td>\n<td>Rs 1,302<\/td>\n<\/tr>\n<tr>\n<td>52-Week Low<\/td>\n<td>Rs 752<\/td>\n<\/tr>\n<tr>\n<td>Market Cap<\/td>\n<td>Rs 12,600 Cr<\/td>\n<\/tr>\n<tr>\n<td>P\/E<\/td>\n<td>22x<\/td>\n<\/tr>\n<tr>\n<td>Promoter<\/td>\n<td>52.6%<\/td>\n<\/tr>\n<tr>\n<td>FII<\/td>\n<td>14.8%<\/td>\n<\/tr>\n<tr>\n<td>Dividend FY26<\/td>\n<td>Rs 5<\/td>\n<\/tr>\n<tr>\n<td>Short-Term Target<\/td>\n<td>Rs 1,102<\/td>\n<\/tr>\n<tr>\n<td>12M Target<\/td>\n<td>Rs 1,102-1,282<\/td>\n<\/tr>\n<tr>\n<td>Upside<\/td>\n<td>20-39%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><em>Sources: NSE\/BSE, Screener.in, publicly available analyst research. April 2026.<\/em><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Analyst_Ratings_and_Eris_Lifesciences_share_price_target_2026\"><\/span><strong>Analyst Ratings and Eris Lifesciences share price target 2026<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table border=\"1\" cellspacing=\"0\" cellpadding=\"6\">\n<tbody>\n<tr>\n<th>Brokerage<\/th>\n<th>Rating<\/th>\n<th>Target<\/th>\n<th>Key View<\/th>\n<\/tr>\n<tr>\n<td>MOFSL<\/td>\n<td>Buy<\/td>\n<td>Rs 1,106<\/td>\n<td>FY27 earnings recovery and Pharma sector leadership<\/td>\n<\/tr>\n<tr>\n<td>YES Securities<\/td>\n<td>Buy<\/td>\n<td>Rs 1,124<\/td>\n<td>Quality execution \u2014 accumulate at support levels<\/td>\n<\/tr>\n<tr>\n<td>Kotak Institutional<\/td>\n<td>Add<\/td>\n<td>Rs 1,060<\/td>\n<td>Monitor Q4 FY26 guidance \u2014 maintain position<\/td>\n<\/tr>\n<tr>\n<td>JM Financial<\/td>\n<td>Neutral<\/td>\n<td>Consensus<\/td>\n<td>Await Q4 FY26 result clarity before adding<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><a href=\"https:\/\/univest.in\/user\/log-in\"><strong>Subscribe to Univest Pro for SEBI-registered entry, target and stop-loss on Eris Lifesciences.<\/strong><\/a><\/p>\n<h2><span class=\"ez-toc-section\" id=\"How_to_Invest_in_Eris_Lifesciences_%E2%80%94_5_Steps\"><\/span><strong>How to Invest in Eris Lifesciences \u2014 5 Steps<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Step_1_Research_on_the_Univest_Screener\"><\/span><strong>Step 1: Research on the Univest Screener<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Search ERIS on <a href=\"https:\/\/univest.in\/screeners\">univest.in\/screeners<\/a>. Review quarterly results, FII\/DII trend, promoter holding, and analyst consensus on the <strong>Eris Lifesciences share price target 2026<\/strong>.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Step_2_Identify_Entry_Level\"><\/span><strong>Step 2: Identify Entry Level<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Eris Lifesciences at Rs 922 has key support near Rs 752. Plan entry near support with stop-loss 8-10% below entry. First resistance toward the <strong>Eris Lifesciences share price target 2026<\/strong> recovery is Rs 1,102.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Step_3_Monitor_Q4_FY26_Results\"><\/span><strong>Step 3: Monitor Q4 FY26 Results<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Q4 FY26 results (April-May 2026) are the near-term trigger. A beat with positive FY27 guidance triggers re-rating toward 1,282 \u2014 the bull case for the <strong>Eris Lifesciences share price target 2026<\/strong>.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Step_4_Position_Sizing\"><\/span><strong>Step 4: Position Sizing<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Allocate maximum 3-5% of your portfolio to any single stock. Never invest more than you can hold for 2+ years through volatility.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Step_5_Track_on_the_Univest_App\"><\/span><strong>Step 5: Track on the Univest App<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&amp;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Android App<\/a> for live price alerts and SEBI-registered research aligned with the <strong>Eris Lifesciences share price target 2026<\/strong>.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Conclusion_%E2%80%94_Eris_Lifesciences_share_price_target_2026\"><\/span><strong>Conclusion \u2014 Eris Lifesciences share price target 2026<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Eris Lifesciences (ERIS) at Rs 922 offers 20-39% potential upside to the 12-month <strong>Eris Lifesciences share price target 2026<\/strong> consensus of Rs 1,102-1,282. The bull case to 1,282 requires FY27 earnings delivery and macro normalisation. The bear case (Rs 752 zone) materialises only on significant earnings disappointment. For long-term investors with a 2-3 year horizon, Eris Lifesciences at current levels presents a monitored entry opportunity. For more <strong>Eris Lifesciences share price target 2026<\/strong> analysis and peer comparisons, <a href=\"https:\/\/univest.in\/blogs\"><strong>visit Univest Blogs<\/strong><\/a>.<\/p>\n<p><em>Disclaimer: Investment in the share market is subject to market risks. This article is for educational and informational purposes only and does not constitute investment advice. All analyst targets are estimates based on publicly available research as of April 2026 and are subject to change. Verify all data on NSE\/BSE before investing. Consult a SEBI-registered financial advisor before making any investment decisions.<\/em><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions_%E2%80%94_Eris_Lifesciences_share_price_target_2026\"><\/span><strong>Frequently Asked Questions \u2014 Eris Lifesciences share price target 2026<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Q_What_is_Eris_Lifesciences_share_price_target_for_2026\"><\/span><strong>Q: What is Eris Lifesciences share price target for 2026?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The 12-month <strong>Eris Lifesciences share price target 2026<\/strong> analyst consensus is Rs 1,102-1,282 \u2014 implying 20-39% upside from CMP Rs 922. Bull case: 1,282. Bear case: Rs 752 zone. Track the live Eris Lifesciences share price target 2026 on the Univest Screener. These are analyst estimates, not guaranteed returns.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Q_Is_Eris_Lifesciences_a_good_buy_at_Rs_922\"><\/span><strong>Q: Is Eris Lifesciences a good buy at Rs 922?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>This article does not constitute investment advice. At Rs 922, Eris Lifesciences offers 20-39% upside to the Eris Lifesciences share price target 2026 consensus of Rs 1,102-1,282. Suitability depends on your risk tolerance and investment horizon. Consult a SEBI-registered financial advisor before investing.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Q_What_is_Eris_Lifesciences_52-week_high_and_low\"><\/span><strong>Q: What is Eris Lifesciences 52-week high and low?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Eris Lifesciences&#8217;s 52-week high is Rs 1,302 and 52-week low is Rs 752. At the current CMP of Rs 922, the stock has corrected from its 52-week high \u2014 creating recovery potential for investors aligned with the <strong>Eris Lifesciences share price target 2026<\/strong> thesis.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Q_What_sector_is_Eris_Lifesciences_ERIS_in\"><\/span><strong>Q: What sector is Eris Lifesciences (ERIS) in?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Eris Lifesciences operates in the Pharma \/ Chronic Therapy \/ Lifestyle Diseases sector. India&#8217;s Pharma sector is growing structurally \u2014 driven by rising incomes, government policy, and India&#8217;s consumption expansion \u2014 underpinning the Eris Lifesciences share price target 2026 bull case.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Q_What_are_the_main_risks_for_the_Eris_Lifesciences_share_price_target_2026_thesis\"><\/span><strong>Q: What are the main risks for the Eris Lifesciences share price target 2026 thesis?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Key risks: US tariff macro headwinds, valuation at 22x requiring consistent execution, competition in Pharma, input cost volatility, and FII selling pressure (14.8% holding). Monitor quarterly earnings closely.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Q_What_is_Eris_Lifesciencess_market_cap\"><\/span><strong>Q: What is Eris Lifesciences&#8217;s market cap?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Eris Lifesciences has a market cap of Rs 12,600 Cr as of April 2026. At the <strong>Eris Lifesciences share price target 2026<\/strong> of Rs 1,102-1,282, the implied market cap would reflect 20-39% appreciation on the current base.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Q_What_is_Eris_Lifesciences_dividend_for_FY26\"><\/span><strong>Q: What is Eris Lifesciences dividend for FY26?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Eris Lifesciences&#8217;s FY26 dividend is Rs 5. Track dividend announcements on NSE or the Univest Screener. Dividend yield adds to the total return alongside the <strong>Eris Lifesciences share price target 2026<\/strong> capital appreciation potential.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Q_How_to_buy_Eris_Lifesciences_shares\"><\/span><strong>Q: How to buy Eris Lifesciences shares?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Buy Eris Lifesciences (ERIS) through any SEBI-registered broker on NSE. Research first on the Univest Screener, set a price alert at the Rs 752 support zone, and download the Univest App for SEBI-registered research on the <strong>Eris Lifesciences share price target 2026<\/strong>.<\/p>\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Recent_Article\"><\/span><strong>Recent Article<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p><a href=\"https:\/\/univest.in\/blogs\/zuari-agro-chemicals-q4-results-2026\">Zuari Agro Chemicals Q4 Results 2026: Date, Revenue, PAT and Analyst Outlook<\/a><\/p>\n<p><a href=\"https:\/\/univest.in\/blogs\/zota-health-care-q4-results-2026\">Zota Health Care Q4 Results 2026: Date, Revenue, PAT and Analyst Outlook<\/a><\/p>\n<p><a href=\"https:\/\/univest.in\/blogs\/zodiac-energy-q4-results-2026\">Zodiac Energy Q4 Results 2026: Date, Revenue, PAT and Analyst Outlook<\/a><\/p>\n<p><a href=\"https:\/\/univest.in\/blogs\/zodiac-clothing-company-q4-results-2026\">Zodiac Clothing Company Q4 Results 2026: Date, Revenue, PAT and Analyst Outlook<\/a><\/p>\n<p><a href=\"https:\/\/univest.in\/blogs\/zim-laboratories-q4-results-2026\">Zim Laboratories Q4 Results 2026: Date, Revenue, PAT and Analyst Outlook<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>The Eris Lifesciences share price target 2026 stands at Rs 1,102-1,282 as per analyst consensus \u2014 implying 20-39% upside from the current CMP of Rs 922&#8230;.<\/p>\n","protected":false},"author":26,"featured_media":76322,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[],"class_list":["post-75612","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_edit_lock":["1776937368:26"],"_last_editor_used_jetpack":["block-editor"],"rank_math_primary_category":["842"],"rank_math_seo_score":["76"],"rank_math_focus_keyword":["Eris Lifesciences"],"rank_math_title":["Eris Lifesciences Share Price Target 2026 \u2014 Analyst Forecast, Catalysts and Key Risks"],"rank_math_description":["The Eris Lifesciences share price target 2026 stands at Rs 1,102-1,282 as per analyst consensus \u2014 implying 20-39% upside from the current CMP of Rs 922...."],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"],"_wp_old_date":["2026-04-22"],"_thumbnail_id":["76322"],"_edit_last":["26"],"_ez-toc-disabled":[""],"_ez-toc-insert":[""],"_ez-toc-header-label":[""],"_ez-toc-alignment":["none"],"_ez-toc-heading-levels":["a:0:{}"],"_ez-toc-alttext":[""],"_ez-toc-visibility_hide_by_default":[""],"_ez-toc-hide_counter":[""],"_ez-toc-exclude":[""],"_ez-toc-position-specific":["before"],"stm_select_gm_zoom":[""],"stm_agenda":[""],"stm_host":[""],"stm_select_approved_denied":[""],"stm_multiselect_approved":[""],"stm_multiselect_denied":[""],"stm_date":[""],"stm_time":[""],"stm_timezone":[""],"stm_duration":[""],"stm_password":[""],"stm_waiting_room":[""],"stm_join_before_host":[""],"stm_host_join_start":[""],"stm_start_after_participants":[""],"stm_mute_participants":[""],"stm_enforce_login":[""],"stm_alternative_hosts":[""],"top_bar_custom_style":[""],"top_bar_bg":[""],"wc_top_bar_cart_custom_style":[""],"wc_top_bar_cart_color":[""],"wc_top_bar_cart_icon_color_hover":[""],"wc_top_bar_cart_counter_color":[""],"wc_top_bar_cart_counter_color_hover":[""],"wc_top_bar_cart_counter_bg":[""],"wc_top_bar_cart_counter_bg_hover":[""],"top_bar_wpml_switcher_custom_style":[""],"wpml_switcher_color":[""],"top_bar_wpml_switcher_bg":[""],"top_bar_wpml_switcher_bg_hover":[""],"top_bar_wpml_switcher_color_hover":[""],"top_bar_socials_custom_style":[""],"top_bar_socials_color":[""],"top_bar_socials_color_hover":[""],"top_bar_search_custom_style":[""],"top_bar_search_color":[""],"top_bar_search_icon_color_hover":[""],"top_bar_contact_info_style":[""],"top_bar_contact_info_color":[""],"top_bar_contact_info_link_color":[""],"top_bar_contact_info_link_color_hover":[""],"top_bar_contact_info_select_bg":[""],"top_bar_contact_info_select_color":[""],"top_bar_contact_info_select_drop_bg":[""],"top_bar_contact_info_select_items_bg":[""],"top_bar_contact_info_select_items_color":[""],"top_bar_contact_info_select_items_hover":[""],"header_inverse":["default"],"enable_header_transparent":["off"],"header_nav_custom_style":[""],"header_bg":[""],"header_shadow":[""],"wc_cart_custom_style":[""],"wc_cart_icon_color":[""],"wc_cart_icon_color_hover":[""],"wc_cart_counter_color":[""],"wc_cart_counter_color_hover":[""],"wc_cart_counter_bg":[""],"wc_cart_counter_bg_hover":[""],"header_wpml_switcher_custom_style":[""],"header_wpml_switcher_color":[""],"header_wpml_switcher_color_hover":[""],"header_wpml_switcher_bg":[""],"header_wpml_switcher_bg_hover":[""],"header_socials_custom_style":[""],"header_socials_color":[""],"header_socials_color_hover":[""],"header_search_custom_style":[""],"header_search_icon_color":[""],"header_search_icon_color_hover":[""],"header_contact_info_style":[""],"header_contact_info_color":[""],"header_contact_info_link_color":[""],"header_contact_info_link_color_hover":[""],"header_button_custom_style":[""],"header_button_color":[""],"header_button_color_hover":[""],"header_button_bg":[""],"header_button_bg_hover":[""],"header_nav_menu_customize":[""],"header_nav_menu_link_color":[""],"header_nav_menu_link_color_hover":[""],"header_nav_menu_link_color_active":[""],"header_nav_menu_link_arrow_color":[""],"header_nav_menu_link_arrow_color_hover":[""],"header_nav_menu_level_1_bg":[""],"header_nav_menu_level_1_link_color":[""],"header_nav_menu_level_1_link_color_hover":[""],"header_nav_menu_level_1_link_bg_hover":[""],"header_nav_menu_level_1_link_arrow_color":[""],"header_nav_menu_level_1_link_arrow_color_hover":[""],"header_nav_menu_level_2_bg":[""],"header_nav_menu_level_2_link_color":[""],"header_nav_menu_level_2_link_color_hover":[""],"header_nav_menu_level_2_link_bg_hover":[""],"header_mega_menu_bg":[""],"header_mega_menu_title_color":[""],"header_mega_menu_title_color_hover":[""],"header_mega_menu_description_color":[""],"header_mega_menu_description_link_color":[""],"header_mega_menu_description_link_color_hover":[""],"header_mega_menu_color":[""],"header_mega_menu_color_hover":[""],"header_mega_menu_border_color":[""],"header_mega_menu_icons_color":[""],"header_nav_menu_customize_end":[""],"hfe_enabled_notice":[""],"disable_title_box":["default"],"hfe_disabled":[""],"enable_transparent":["default"],"title_box_title_bg_color":[""],"title_box_bg_custom_image":["default"],"title_box_bg_image":[""],"title_box_bg_position":["default"],"metabox_title_box_bg_position_x":[""],"metabox_title_box_bg_position_y":[""],"metabox_title_box_bg_attachment":["default"],"title_box_bg_size":["default"],"metabox_title_box_bg_size_slider":[""],"title_box_bg_repeat":["default"],"disable_title":["default"],"title_box_title_color":[""],"title_box_title_line_color":[""],"disable_breadcrumbs":["default"],"metabox_title_box_breadcrumbs_color":[""],"metabox_title_box_links_color":[""],"metabox_title_box_links_color_hover":[""],"content_bg_transparent":[""],"show_popup_single":[""],"popups_single":[""],"popups_single_event":[""],"popup_single_event_open_delay":[""],"popup_single_event_showing_in":[""],"popup_single_event_date_from":[""],"popup_single_event_date_to":[""],"popup_single_event_time_from":[""],"popup_single_event_time_to":[""],"popup_single_animation":[""],"popup_single_responsive":[""],"separator_footer_copyright_border_t":[""],"name":[""],"email":[""],"phone":[""],"company":[""],"memberId":[""],"testimonial_position":[""],"testimonial_company":[""],"testimonial_bg_img":[""],"testimonial_video_url":[""],"popups_width":[""],"popups_height":[""],"popups_image_bg":[""],"popups_color_bg":[""],"popups_border_radius":[""],"popups_template":[""],"rank_math_analytic_object_id":["8971"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/04\/23151018\/Eris-Lifesciences-1.jpg","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/75612","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/26"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=75612"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/75612\/revisions"}],"predecessor-version":[{"id":76323,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/75612\/revisions\/76323"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/76322"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=75612"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=75612"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=75612"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}